Cited by 34Pancreatic function and diabetesCellular transport and secretionMetabolism, Diabetes, and Cancer

DOC2 isoforms play dual roles in insulin secretion and insulin-stimulated glucose uptake

Li, Jia, Cantley, James, Burchfield, James G., Meoli, Christopher C., Stöckli, Jacqueline, Whitworth, P. Tess, Pant, Himani, Chaudhuri, Rima +3 more·2014·Diabetologia

Abstract

Aims/hypothesis Glucose-stimulated insulin secretion (GSIS) and insulin-stimulated glucose uptake are processes that rely on regulated intracellular vesicle transport and vesicle fusion with the plasma membrane. DOC2A and DOC2B are calcium-sensitive proteins that were identified as key components of vesicle exocytosis in neurons. Our aim was to investigate the role of DOC2 isoforms in glucose homeostasis, insulin secretion and insulin action. Methods DOC2 expression was measured by RT-PCR and western blotting. Body weight, glucose tolerance, insulin action and GSIS were assessed in wild-type (WT), Doc2a (-/-) (Doc2aKO), Doc2b (-/-) (Doc2bKO) and Doc2a (-/-)/Doc2b (-/-) (Doc2a/Doc2bKO) mice in vivo. In vitro GSIS and glucose uptake were assessed in isolated tissues, and exocytotic proteins measured by western blotting. GLUT4 translocation was assessed by epifluorescence microscopy. Results Doc2b mRNA was detected in all tissues tested, whereas Doc2a was only detected in islets and the brain. Doc2aKO and Doc2bKO mice had minor glucose intolerance, while Doc2a/Doc2bKO mice showed pronounced glucose intolerance. GSIS was markedly impaired in Doc2a/Doc2bKO mice in vivo, and in isolated Doc2a/Doc2bKO islets in vitro. In contrast, Doc2bKO mice had only subtle defects in insulin secretion in vivo. Insulin action was impaired to a similar degree in both Doc2bKO and Doc2a/Doc2bKO mice. In vitro insulin-stimulated glucose transport and GLUT4 vesicle fusion were defective in adipocytes d…

Integrity signals

Registry

Crossref · 10.1007/s00125-014-3312-y

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Ablation of Doc2a, Doc2b, or both leads to deterioration of glucose tolerance.

    “In contrast, ablation of Doc2a, Doc2b, or both Doc2a and Doc2b leads to deterioration of glucose tolerance.”
  • Even when both Doc2a and Doc2b are ablated, the reduction in secretion is limited to 20%.

    “and even when both are ablated the reduction in secretion is limited to 20% (391).”
  • A transgenic mouse overexpressing Doc2b has improved glucose tolerance and increased GIIS, mainly due to increased 2nd phase secretion.

    “A transgenic mouse overexpressing Doc2b has improved glucose tolerance and increased GIIS (mainly due to increased 2nd phase secretion).”
  • The effect of ablating either Doc2a or Doc2b alone on glucose-induced insulin release is marginal, both in vivo and in vitro.

    “However, the effect of ablating either Doc2a or Doc2b alone on glucose-induced insulin release is marginal, both in vivo and in vitro,”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Li, J., Cantley, J., Burchfield, J. G., Meoli, C. C., Stöckli, J., Whitworth, P. T., Pant, H., Chaudhuri, R., Groffen, A. J. A., Verhage, M., & James, D. E.
Affiliations
  • Garvan Institute of Medical Research (AU)
  • Amsterdam Neuroscience (NL)
  • The University of Sydney (AU)
Corresponding author
James, David E.
Venue
Diabetologia
Published
2014-07-09
Volume
57
Issue
10
Pages
2173-2182
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2035201451
Cited by
34
References
1
Citations by year
2025: 2 · 2024: 1 · 2023: 4 · 2022: 6 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 3 · 2015: 1 · 2014: 3
FWCI
3.97
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
  • VU Research Portal (publishedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • VU Research Portal (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
DOC2B, glucose-stimulated insulin secretion, insulin-stimulated glucose uptake, insulin action, impaired glucose tolerance, pancreatic beta cells, adipocytes, GLUT4 translocation, vesicle exocytosis, vesicle fusion, glucose homeostasis, knockout mice
MeSH terms
Insulin Secretion, Animals, Biological Transport, Calcium-Binding Proteins, Glucose, Insulin, Male, Nerve Tissue Proteins, Adipocytes, Mice, Knockout, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review